Prelude Therapeutics

PRLD

Börsenwert 260 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
26	26 Bank of New York Mellon New York	363.436 $	+296.791 $	+68.187	Neu
27	27 Charles Schwab San Francisco, California	360.425 $	+294.332 $	+67.622	Neu
28	28 Bridgeway Capital Management Houston, Texas	343.785 $	+47.879 $	+11.000	+21 %
29	29 Squarepoint New York	317.348 $	+259.154 $	+59.540	Neu
30	30 Panagora Asset Management Boston, Massachusetts	253.569 $	+207.071 $	+47.574	Neu
31	31 Mariner Overland Park, Kansas	241.241 $	+197.003 $	+45.261	Neu
32	32 Nuveen Charlotte, North Carolina	197.333 $	+161.146 $	+37.023	Neu
33	33 Dimensional Fund Advisors Austin, Texas	186.839 $	–	–	–
34	34 Invesco Atlanta, Georgia	185.175 $	+151.218 $	+34.742	Neu
35	35 Cerity Partners New York	175.224 $	–	–	–
36	36 State of Wyoming Cheyenne, Wyoming	175.154 $	+143.035 $	+32.862	Neu
37	37 Graham Capital Management Rowayton, Connecticut	158.674 $	+80.205 $	+18.427	+162 %
38	38 Deutsche Bank Frankfurt Am Main Ge, Germany	148.302 $	+121.107 $	+27.824	Neu
39	39 Wells Fargo San Francisco, California	134.982 $	+110.230 $	+25.325	Neu
40	40 Bank of America Charlotte, North Carolina	127.254 $	-142.112 $	-32.650	-58 %
41	41 T. Rowe Price Associates Baltimore, Maryland	122.000 $	+99.056 $	+22.758	Neu
42	42 Citadel Advisors Miami, Florida	120.213 $	-443.199 $	-101.824	-82 %
43	43 RhumbLine Advisers Boston, Massachusetts	117.649 $	+96.079 $	+22.074	Neu
44	44 Vanguard Global Advisers Malvern, Pennsylvania	86.399 $	+50.377 $	+11.574	+250 %
45	45 ExodusPoint Capital Management New York	82.482 $	+67.356 $	+15.475	Neu
46	46 Barclays London, United Kingdom	77.439 $	+25.807 $	+5.929	+69 %
47	47 New York State Common Retirement Fund Albany, New York	75.686 $	+61.807 $	+14.200	Neu
48	48 HSBC Holdings London, United Kingdom	74.403 $	–	–	–
49	49 Mangrove Partners Greenwich, Connecticut	71.166 $	+58.116 $	+13.352	Neu
50	50 Qube Research & Technologies (QRT) London, United Kingdom	69.876 $	-14.394 $	-3.307	-20 %

Prelude Therapeutics PRLD Börsenwert 260 Mio. $

Prelude Therapeutics

PRLD

Börsenwert 260 Mio. $